Infant Nutrition Market

• Tata Consumer Products (India) had entered advanced talks to acquire Danone India’s specialised nutrition and nutraceutical portfolio, including Protinex, strengthening its position in high-margin wellness and nutrition categories. The move had marked TCPL’s deeper push into protein and preventive-health-focused segments, historically linked to both adult and infant nutrition. (December, 2025)

Drivers: Rising Female Workforce Participation and Urbanization

A major driver of the global infant nutrition market is the steady increase in female workforce participation and rapid urbanization, which is reshaping feeding practices for infants. As more women enter full-time employment, the need for convenient, nutritionally balanced alternatives to breastfeeding continues to rise. According to the World Health Organization (WHO), global exclusive breastfeeding rates for infants under six months increased to 48% in 2024, yet more than half of infants still depend on supplemental or full-formula feeding, creating strong demand for high-quality infant nutrition products.

Urban centers, particularly in India, where the infant nutrition market reached USD 1.18 billion in 2025, are witnessing lifestyle shifts that favor ready-to-feed (RTF) and powder formula options designed for time-pressed, dual-income families. Leading brands such as Nestlé and Danone are expanding portfolios with premium, science-backed formulas enriched with DHA, probiotics, and HMOs to support immunity and brain development. Rising disposable incomes also enable parents to choose premium and specialized products, driving further growth. Together, these socio-economic changes fuel consistent demand for innovative, safe, and convenient infant nutrition solutions globally.

Opportunities: Innovation in Human Milk Oligosaccharides (HMOs)

The rise of Human Milk Oligosaccharides (HMOs) presents one of the most promising opportunities in the global infant nutrition market, as HMOs allow infant formula to more closely replicate the immune-supporting benefits of natural breast milk. HMOs are complex carbohydrates that play a crucial role in shaping the infant gut microbiome, enhancing immunity, and supporting long-term health. With growing scientific validation and regulatory acceptance, the HMO ingredients segment is projected to grow at a CAGR of 14.5%, making it one of the fastest-expanding categories in pediatric nutrition.

In January 2025, Nestlé accelerated innovation by launching NAN Sinergity, an ultra-premium formula featuring six HMOs combined with targeted probiotics, designed to support gut health and early immune development. This aligns with parents’ increasing demand for premium, science-driven formulas that mimic breast milk. Regulatory developments such as the FDA’s “Operation Stork Speed” in March 2025 have further improved the pathway for approval of advanced bio-synthetic ingredients, strengthening consumer trust and enabling companies to bring innovative formulations to market faster. As parents prioritize safety and enhanced nutrition, HMOs are expected to reshape premium infant formula offerings globally.

Challenges: Demographic Declines and Stringent Regulatory Oversight

The global infant nutrition market faces significant challenges from declining birth rates and increasing regulatory pressure across key markets. China, historically the world’s largest infant formula market, has experienced a steep drop in births—from 13.03‰ in 2013 to 6.39‰ in 2023—resulting in a projected 2% market contraction to USD 37.2 billion by 2025. Leading players such as China Feihe have already reported declining revenues due to shrinking population cohorts, intensifying competition, and changing consumer preferences.

At the same time, the industry must comply with highly stringent regulations, particularly in the United States. The USDA’s WIC program, which supports around 41% of U.S. infants, requires formula manufacturers to offer rebates averaging 108.6% of wholesale prices in 2025 to secure exclusive state contracts. These high rebate costs significantly reduce margins and create high barriers for new entrants. Adding to this pressure, recent contamination concerns have prompted the FDA to introduce tighter safety and quality standards, increasing production and compliance costs for manufacturers. Together, demographic decline and regulatory burdens create a challenging operating environment, slowing market expansion and reshaping competitive strategies worldwide

The global infant nutrition market is a fast-growing segment of the pediatric health and food industry, focused on products such as infant formula, follow-on formula, baby cereals, and fortified baby foods. The market was valued at USD 89 billion in 2024 and is projected to reach USD 138.1 billion by 2030, registering a CAGR of about 7.6 %. This growth is driven by rising demand for safe, high-quality baby food, increasing female workforce participation, and a stronger shift toward premium, organic, and hypoallergenic formulas. Key trends shaping the market include the adoption of HMO-based formulas, probiotic and synbiotic blends, and plant-based infant nutrition. Manufacturers are focusing on clean-label ingredients, better safety standards, and sustainable sourcing following global recalls and heightened regulatory scrutiny. Growing awareness of early-life nutrition and its impact on immunity and brain development is further boosting product innovation and investment across the infant nutrition industry